Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-29T02:44:37.392Z Has data issue: false hasContentIssue false
  • English
  • Français

Variation in Antibiotic Prophylaxis Selection for Coronary Artery Bypass Graft Procedures in an Era of Increasing Methicillin-Resistant Staphylococcus aureus Prevalence

Published online by Cambridge University Press:  10 May 2016

Peter P. Hsiue ,
Aric L. Gregson ,
Patil Injean ,
Sitaram Vangala ,
Ralph G. Brindis ,
Richard J. Shemin ,
David M. Shahian ,
Loren G. Miller ,
Martin F. Shapiro  and
Peyman Benharash
...Show all authors
Peter P. Hsiue
Affiliation:
Division of Infectious Disease, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California
Aric L. Gregson
Affiliation:
Division of Infectious Disease, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California
Patil Injean
Affiliation:
Division of Infectious Disease, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California
Sitaram Vangala
Affiliation:
Division of Infectious Disease, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California
Ralph G. Brindis
Affiliation:
University of California, Philip R. Lee Institute for Health Policy Studies, San Francisco, California
Richard J. Shemin
Affiliation:
Division of Cardiothoracic Surgery, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, California
David M. Shahian
Affiliation:
Massachusetts General Hospital Center for Quality and Safety, Boston, Massachusetts
Loren G. Miller
Affiliation:
Infectious Disease Clinical Outcomes Research at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California
Martin F. Shapiro
Affiliation:
Division of General Internal Medicine and Health Services Research, University of California, Los Angeles, California
Peyman Benharash
Affiliation:
Division of Cardiothoracic Surgery, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, California
James A. McKinnell*
Affiliation:
Infectious Disease Clinical Outcomes Research at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California
*
Infectious Disease Clinical Outcomes Research Unit, Division of Infectious Disease, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, 1124 West Carson Street, Torrance, CA 90502 ([email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Research Briefs
Information
Infection Control & Hospital Epidemiology , Volume 35 , Issue 6 , 01 June 2014 , pp. 737 - 740
Copyright
© 2014 by The Society for Healthcare Epidemiology of America. All rights reserved.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Grover, A, Gorman, K, Dall, TM, et al. Shortage of cardiothoracic surgeons is likely by 2020. Circulation 2009;120(6):488–494.Google Scholar
2. Kreter, B, Woods, M. Antibiotic prophylaxis for cardiothoracic operations. Meta-analysis of thirty years of clinical trials. J Thorac Cardiovasc Surg 1992;104(3):590–599.Google Scholar
3. Bratzler, DW, Dellinger, EP, Olsen, KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013;70(3):195–283.CrossRefGoogle ScholarPubMed
4. Engelman, R, Shahian, D, Shemin, R, et al. The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part II. Antibiotic choice. Ann Thorac Surg 2007;83(4):1569–1576.Google Scholar
5. California Department of Public Health. Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) bloodstream infections (BSI) in California hospitals, 2011. http://www.cdph.ca.gov/programs/hai/Pages/MRSAandVRE-Report.aspx. Accessed September 10, 2013.Google Scholar
6. California Office of Statewide Health, Planning, and Development. The California report on coronary artery bypass graft surgery 2009–2010. http://www.oshpd.ca.gov/HID/Products/Clinical_Data/CABG/2010/HospitalResults-HospitalMortality.pdf. Accessed September, 10, 2013.Google Scholar
7. Bolon, MK, Morlote, M, Weber, SG, Koplan, B, Carmeli, Y, Wright, SB. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin Infect Dis 2004;38(10):1357–1363.Google Scholar
8. Miller, LG, McKinnell, JA, Vollmer, ME, Spellberg, B. Impact of methicillin-resistant Staphylococcus aureus prevalence among S. aureus isolates on surgical site infection risk after coronary artery bypass surgery. Infect Control Hosp Epidemiol 2011;32(4):342–350.Google Scholar
9. Lauer, MS, D’Agostino, RB Sr. The randomized registry trial: the next disruptive technology in clinical research? N Engl J Med 2013;369(17):1579–1581.Google Scholar
10. Welke, KF, Ferguson, TB Jr, Coombs, LP, et al. Validity of the Society of Thoracic Surgeons National Adult Cardiac Surgery Database. Ann Thorac Surg 2004;77(4):1137–1139.Google Scholar